Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-SN-26-67
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC11
Additional Details
Documents2
The Defense Advanced Research Projects Agency (DARPA), operating under the Department of Defense, has issued a Special Notice (DARPA-SN-26-67) announcing a research opportunity titled "DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)." This initiative seeks innovative proposals aimed at demonstrating proof-of-concept for novel mechanisms that can write and erase epigenetic base modifications in DNA. The overarching purpose of this procurement is to advance the scientific understanding and technological capabilities related to the manipulation of the epigenome, specifically focusing on the development of new methods to control DNA-protein interactions and to explore the functions and potential applications of rare or novel epigenetic modifications.
The scope of the D-PECHE program is centered on the creation and demonstration of technologies capable of modifying nucleic acids in vitro. Successful proposals are expected to deliver tangible proof-of-concept demonstrations that showcase the ability to engineer and reverse specific epigenetic marks on DNA. These outcomes are anticipated to open new avenues for research into the regulation of gene expression, the study of epigenetic phenomena, and the development of tools for biotechnology and synthetic biology applications.
Key requirements for this opportunity include the submission of innovative technical approaches that address the challenge of precise and reversible epigenetic modification. Proposals should clearly articulate the mechanisms by which DNA-protein interactions can be modulated through engineered chemical modifications, and must demonstrate the feasibility of these approaches in a controlled laboratory setting. The expected deliverables are robust, reproducible demonstrations of novel epigenetic engineering technologies, with an emphasis on mechanisms that are both effective and reversible.
This procurement is classified under NAICS code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and is further identified by Product Service Code AC11. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), specifically the Biological Technologies Office (BTO). The primary point of contact for this opportunity is Dr. Aric Lu, who can be reached via email at [email protected].
The notice is currently active, with a posting date of May 18, 2026, and a response deadline of June 24, 2026. Interested parties are encouraged to review the updated submission instructions and deadlines as clarified in Amendment 1 of the Special Notice. All relevant documentation and attachments can be accessed through the official SAM.gov opportunity listing at https://sam.gov/opp/553632b7e7fd49a7884a1c32f8a611c5/view.
This is a research and development opportunity, not a traditional procurement for goods or services, and as such, it is designed to attract organizations with advanced capabilities in biotechnology, molecular biology, and epigenetics. There are no set-aside requirements or special considerations specified in the notice. Contractors with expertise in the engineering of nucleic acid modifications and the development of novel biochemical tools are particularly well-suited to respond to this solicitation.
Overall, the D-PECHE program represents a significant opportunity for research organizations to contribute to the next generation of epigenetic engineering technologies, with the potential for broad impact across the fields of biotechnology, medicine, and synthetic biology.